When talented PharmDs start calculating whether another country offers a better professional life, the profession has a structural problem. Not a resilience problem. Not a wellness webinar problem. A structural one.
Pharmacy Times flagged the story this week: pharmacists in growing numbers are exploring relocation to New Zealand for better work-life balance. The conversation is happening in pharmacy forums, professional networks, and increasingly, in direct messages to relocation services that now help hundreds of American pharmacists make the move. This newsletter won’t bury the signal in the noise.
What the American Pharmacy Workforce Data Actually Shows
The New Zealand story doesn’t exist in isolation. It is the predictable output of a documented workforce crisis that has been building for years.
The 2024 National Pharmacist Workforce Study reports that 73% of pharmacists working full-time rated their workload as “high” or “excessively high.” Just under half somewhat or strongly agreed that their professional environment was unsustainable.
A systematic review found that more than half (51%) of pharmacists are experiencing burnout, with high prescription volumes, excessive workload, poor work-life balance, and staffing shortages among the leading causes. A 2025 report from APhA, ASHP, and NABP acknowledged what many pharmacists already know: the profession has been at a breaking point.
In North American hospital and retail settings, burnout is associated with increased sick leave and stronger intentions to leave the profession, undermining continuity of care and institutional memory. When turnover accelerates, the tacit knowledge and coordinated team performance that pharmacy depends on is lost, directly affecting patient safety. The ASHP Burnout Calculator frames investment in workforce wellbeing as a cost-containment strategy, not an optional wellness initiative.
The profession’s three leading national organizations, APhA, ASHP, and NABP, convened their second Implementing Solutions Summit in June 2025. The summit brought together over 80 pharmacy professionals across all practice settings to share progress, explore challenges, and identify new strategies to improve workplace conditions. Leaders acknowledged the emotional toll that high-stress environments take on pharmacists and the ongoing stigma surrounding mental health support.
Summits are useful. But summits don’t fix what pharmacists describe when they talk about why they’re researching New Zealand.
What New Zealand Actually Offers
The pharmacists exploring relocation describe something specific, and it isn’t primarily about salary or scenery.
One pharmacist who made the move told Pharmacy Times: “For the first time in years, I finished a shift and actually had energy left.” Recovery time matters. Burnout isn’t only about what happens during a shift, it’s about whether you have time to recover before the next one.
Several describe the difference as cultural: they feel more able to flag a concern, say “This isn’t safe,” or advocate for a patient without assuming they will be dismissed or disciplined for doing so.
The structural difference is real. New Zealand’s pharmacy system is built on a fundamentally different model of professional role.
New Zealand’s pharmacy profession has three scopes of practice, intern pharmacist, pharmacist, and pharmacist prescriber. The pharmacist prescriber scope allows suitably qualified pharmacists to provide individualized medicines management services, including prescribing medicines to patients across a range of healthcare settings. Pharmacist prescribers work in collaborative health team environments and can write prescriptions to initiate, modify, or discontinue therapy.
The new 12-month prescription cycle in New Zealand means pharmacists see the same patients consistently over a full year without the friction of requiring a return visit to a physician for routine renewal. This fosters a level of patient trust and continuity of care that is structurally absent in most American retail models. The system actively seeks clinical leaders who want to practice at the top of their scope.
New Zealand has placed pharmacists on Tier 1 of the Immigration Green List, the highest-priority category, providing a pathway to permanent residency before arrival. This streamlined credentialing process reflects how seriously the country takes its pharmacist shortage.
This Isn’t About New Zealand. It’s About What American Pharmacy Is Not Offering.
The honest read on this story has nothing to do with New Zealand’s beaches. It has to do with what happens when a clinically trained, ethically committed, six-figure-debt-holding PharmD looks at their daily workflow and concludes: this is not sustainable.
From a U.S. perspective, it is easy to see international moves as a loss to the domestic workforce. But when so many pharmacists are already thinking about leaving the profession, or have already left, the alternative is not always to stay in the same chain. Sometimes it is to leave patient-facing practice entirely.
In community practice, burnout frequently reflects structural compression driven by extended operating hours, limited staffing, and constant pressure to meet dispensing targets. National surveys consistently report high levels of emotional exhaustion among retail pharmacists, attributed to workload intensity, insufficient recovery time, and commercial expectations that prioritize speed over clinical value. The resulting conflict between the professional obligation to protect patient safety and managerial demands for efficiency generates moral dissonance, a well-established predictor of burnout.
Pharmacists who are leaving the profession often say they are doing so because of professional burnout and insufficient compensation for increased hours and duties in an increasingly high-stress retail environment. Sixty-seven percent of pharmacy owners and managers report difficulty filling open positions, and the pipeline isn’t healing itself.
When those two data points collide, pharmacists leaving because the work is unsustainable, and employers unable to fill the positions they leave, the system has a structural failure, not a recruitment problem.
What Pharmacy Leaders Need to Do Before the Next Shift Change
The New Zealand story is a market signal. When pharmacists actively research a different country’s credentialing process, that is a revealed preference, expressed more clearly than any exit survey or workplace satisfaction score.
The employers, residency programs, and associations that respond with concrete structural change will recruit and retain the best pharmacists in their market. The ones that respond with wellness webinars, resilience training, and token gestures will watch their strongest staff make different calculations.
What structural change looks like, specifically:
Staffing ratios that reflect clinical complexity, not prescription volume targets. The AON pharmacist coaching program covered in a prior issue of this newsletter produced 22 fewer hospital admissions per 100 patients. That’s not possible when a pharmacist fills 300 prescriptions a day alone. You cannot build the clinical model the profession needs without rebuilding the operational model that currently crushes it.
Genuine protected time for clinical work. Not time carved from a lunch break or added to an already unmanageable shift. Dedicated, defended, compensated time for MTM, patient counseling, pharmacogenomics review, and care coordination, the activities that generate clinical outcomes and justify provider status.
Permission culture at the practice level. The cultural difference New Zealand pharmacists describe the ability to flag safety concerns without fear of discipline, is replicable. It requires explicit leadership commitment, not a policy statement. Pharmacy directors who actively invite concern-raising and respond to it constructively retain staff. Those who don’t, don’t.
Compensation structures that reflect scope expansion. If a pharmacist provides a clinical service that generates value, Medicare billing under a collaborative practice agreement, 340B revenue from improved adherence, shared savings from reduced utilization, that value should flow back to the pharmacist. The current compensation model in most retail settings doesn’t make this connection. The sustainable model does.
The Workforce Data to Track
The NABP annual workforce survey for 2026, expected later this year, will be one of the most important data releases in pharmacy this year. Watch specifically for geographic mobility data, whether pharmacists are moving between practice settings, leaving patient-facing roles, or indicating plans to exit the profession within five years.
APhA, ASHP, and NABP committed at the June 2025 summit to ongoing collaboration and development of an organizational assessment tool to promote practices that support well-being. The broader pharmacy profession is encouraged to use the summit’s findings to guide meaningful action for workforce and workplace conditions.
Meaningful action means restructuring workflows, not describing them. It means measurable staffing ratio changes, not aspirational statements. It means acknowledging that the pharmacist researching New Zealand is not a problem employee, they are a data point in a systemic failure that the profession has documented for years and mostly watched.
The pharmacies that build genuinely sustainable practice environments in 2026 will have a decisive competitive advantage in recruitment and retention. Not because of recruitment bonuses or benefit packages. Because they will be the places where pharmacists can finish a shift with energy left.
That is the bar. It should not be this hard to clear.
Sources: Pharmacy Times (Some Pharmacists Find Better Balance in New Zealand, May 2026), APhA / ASHP / NABP (Implementing Solutions 2.0: Building a Sustainable, Healthy, Pharmacy Workforce and Workplace, September 2025), National Pharmacist Workforce Study 2024 (73% Workload Data, Released June 2025), Frontiers in Public Health (Pharmacist Burnout: From Coping to System Accountability, January 2026), NABP Blog (The Changing Pharmacy Landscape and Its Effects on Patient Safety), WorkingIn-Health NZ (Life as a Pharmacist in New Zealand in 2026), Pharmacy Council of New Zealand (Pharmacist Scopes of Practice), Triple0 Medical Recruitment (NZ Pharmacist Career Guide 2026), DIA Global / New Zealand Primary Health Care Journal (Pharmacist Prescribing Models in NZ)